Effectiveness and Safety of Pylera® in Patients Infected by Helicobacter Pylori: A Multicenter, Retrospective, Real Life Study

New bismuth-containing quadruple therapy in patients infected with Helicobacter pylori : A first Italian experience in clinical practice

(2017) Antonio Tursi et al.   HELICOBACTER

Eradication rates in Italian subjects heterogeneously managed for Helicobacter pylori infection. Time to abandon empiric treatments in Southern Europe

(2017)   Journal of Gastrointestinal and Liver Diseases

A real life study of Helicobacter pylori eradication with bismuth quadruple therapy in naïve and previously treated patients

(2017) Blas José Gómez Rodríguez et al.   REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS

Randomized clinical trial comparing ten day concomitant and sequential therapies for Helicobacter pylori eradication in a high clarithromycin resistance area

(2016) Sotirios D. Georgopoulos et al.   European Journal of Internal Medicine

The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults

(2016) Carlo A. Fallone et al.   GASTROENTEROLOGY

Management ofHelicobacter pyloriinfection—the Maastricht V/Florence Consensus Report

(2016) P Malfertheiner et al.   GUT

Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial

(2016) Jyh-Ming Liou et al.   LANCET

Rescue therapy with bismuth-containing quadruple therapy in patients infected with metronidazole-resistant Helicobacter pylori strains

(2016) Nelly Muller et al.   Clinics and Research in Hepatology and Gastroenterology

Efficacy, Tolerability, and Factors Affecting the Efficacy of the Sequential Therapy in Curing Helicobacter Pylori Infection in Clinical Setting

(2016) Antonio Tursi et al.   JOURNAL OF INVESTIGATIVE MEDICINE

Beyond Maastricht IV: are standard empiric triple therapies for Helicobacter pylori still useful in a South-European country?

(2015) Nuno Almeida et al.   BMC GASTROENTEROLOGY

Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015

(2015) Rocco Maurizio Zagari et al.   DIGESTIVE AND LIVER DISEASE

Use of a combination formulation of bismuth, metronidazole and tetracycline with omeprazole as a rescue therapy for eradication ofHelicobacter pylori

(2014) J. C. Delchier et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The Evolution of Helicobacter Pylori Antibiotics Resistance Over 10 Years in Greece

(2014) Georgios P. Karamanolis et al.   DIGESTION

Management ofHelicobacter pyloriinfection—the Maastricht IV/ Florence Consensus Report

(2012) Peter Malfertheiner et al.   GUT

Helicobacter pyloriresistance to antibiotics in Europe and its relationship to antibiotic consumption

(2012) Francis Megraud et al.   GUT

Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial

(2011) Peter Malfertheiner et al.   LANCET

Ten-Day Sequential Treatment forHelicobacter pyloriEradication in Clinical Practice

(2008) Jordi Sánchez-Delgado et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY